Apo-Metoprolol 25 mg tablets: Affected lot may contain over-sized tablets
Brand(s)
Last updated
Summary
Product
Apo-Metoprolol
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Apo-Metoprolol (Metoprolol Tartrate Tablets USP) |
Apo-Metoprolol |
DIN 02246010 |
Tablet |
Metoprolol Tartrate 25 mg |
TW5079 |
Issue
Affected lot may contain over-sized tablets.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesaler, Healthcare Establishments, Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Apotex Inc.
150 Signet Drive
Toronto, Ontario
M9L 1T9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-74727
Get notified
Receive notifications for new and updated recalls and alerts by category.